The Influence of Oxytocin on Intrapartum Fetal Well-being and Delivery Outcomes in Patients Receiving Epidural Analgesia
Launched by CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERNAL AFFAIRS AND ADMINISTRATION, WARSAW, POLAND · May 3, 2024
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a randomized controlled trial performed at the Clinical Department of Obstetrics and Perinatology at the National Medical Institute of the Ministry of the Interior and Administration. The study will recruit 200 patients in either labor induced by oxytocin or stimulated with oxytocin at 37-42 weeks of gestation, requesting the epidural labor analgesia (ELA) and meeting the inclusion criteria. The patients will be individually randomized to either the study group (n=100), in which the use of oxytocin will be continued after the administration of ELA; or to the control group (n=100), i...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • ≥ 18 years old
- • singleton pregnancy
- • labor induced by oxytocin or stimulated with oxytocin
- • signed informed consent form
- • cervical dilation ≥ 3cm
- • patient requesting and eligible for epidural analgesia
- • normal CTG trace for at least 30 minutes before epidural analgesia
- Exclusion Criteria:
- • less than 18 years old
- • preterm delivery
- • multiple pregnancy
- • fetal malformations
- • less than 3cm cervical dilation
- • lack of CTG trace for at least 30 minutes before epidural analgesia
- • patient not requesting or not eligible for epidural analgesia
- • informed consent form not signed
- • spontaneous labor without the use of oxytocin
About Central Clinical Hospital Of The Ministry Of Internal Affairs And Administration, Warsaw, Poland
The Central Clinical Hospital of the Ministry of Internal Affairs and Administration in Warsaw, Poland, is a leading medical institution dedicated to providing high-quality healthcare and advancing medical research. As a prominent clinical trial sponsor, the hospital engages in innovative studies aimed at improving patient outcomes and addressing critical health challenges. With a multidisciplinary team of experienced researchers and healthcare professionals, the hospital fosters a collaborative environment that prioritizes ethical standards and patient safety in clinical research. Its commitment to excellence and continuous improvement positions it as a key player in the advancement of medical science in Poland and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Warsaw, Mazowieckie, Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported